Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis

Cell Cycle

Volumn 6, Issue 10, 2007, Pages 1188-1193

  Gastwirt, Randy F ^a   McAndrew, Christopher W ^a   Donoghue, Daniel J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Apoptosis; Cancer; Cdc2; CDK2; Cell cycle; Checkpoints; Cyclin dependent kinase; RINGO; Speedy

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE; PROTEIN RINGO; PROTEIN SPEEDY; PROTEIN SPY 1; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CELL MATURATION; DNA DAMAGE; HUMAN; MAMMAL; MEIOSIS; NONHUMAN; PROTEIN FUNCTION; REVIEW;

MAMMALIA;

EID: 34548220079     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.10.4252     Document Type: Review

References (38)

1. Zucchi I, Mento E, Kuznetsov VA, Scotti M, Valsecchi V, Simionati B, Vicinanza E, Valle G, Pilotti S, Reinbold R, Vezzoni P, Albertini A, Dulbecco R. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 2004; 101:18147-52.
2. Gutierrez GJ, Vogtlin A, Castro A, Ferby I, Salvagiotto G, Lorca T, Nebreda AR. Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin/proteasome-mediated processing and degradation. 2006, (Gustavo Gutierrez: Personal communication, In review).
3. 2/M progression in Xenopus oocytes. Genes Dev 1999; 13:2177-89.
4. Terret ME, Ferby I, Nebreda AR, Verlhac MH. RINGO efficiently triggers meiosis resumption in mouse oocytes and induces cell cycle arrest in embryos. Biol Cell 2001; 93:89-97.
5. Karaiskou A, Perez LH, Ferby I, Ozon R, Jessus C, Nebreda AR. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins. J Biol Chem 2001; 276:36028-34.
6. 2/M transition. Embo J 1999; 18:1869-77.
7. Kume S, Endo T, Nishimura Y, Kano K, Naito K. Porcine SPDYA2 (RINGO A2) stimulates CDC2 activity and accelerates meiotic maturation of porcine oocytes. Biol Reprod 2007; 76:440-7.
8. Cheng A, Xiong W, Ferrell Jr JE, Solomon MJ. Identification and comparative analysis of multiple mammalian speedy/Ringo proteins. Cell Cycle 2005; 4:155-65.
9. Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, Donoghue DJ. Human Speedy: A novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol 2002; 157:357-66.
10. Dinarina A, Perez LH, Davila A, Schwab M, Hunt T, Nebreda AR. Characterization of a new family of cyclin-dependent kinase activators. Biochem J 2004; 386:349-55.
11. Cheng A, Gerry S, Kaldis P, Solomon MJ. Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem 2005; 6:19.
12. 1/S progression. Mol Biol Cell 2003; 14:3664-74.
13. 2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 2003; 278:21767-73.
14. Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, Harper JW. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 2003; 17:3062-74.
15. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998; 18:629-43.
16. Ogryzko VV, Wong P, Howard BH. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol 1997; 17:4877-82.
17. Barnes EA, Porter LA, Lenormand JL, Dellinger RW, Donoghue DJ. Human Spy1 promotes survival of mammalian cells following DNA damage. Cancer Res 2003; 63:3701-7.
18. Solomon MJ, Glotzer M, Lee TH, Philippe M, Kirschner MW. Cyclin activation of p34cdc2. Cell 1990; 63:1013-24.
19. Savio M, Cerri M, Cazzalini O, Perucca P, Stivala LA, Pichierri P, Franchitto A, Meijer L, Prosperi E. Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins. Cell Cycle 2006; 5:2153-9.
20. Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol Cell Biol 2004; 24:6268-77.
21. Maude SL, Enders GH. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. Cancer Res 2005; 65:780-6.
22. Deans AJ, Khanna KK, McNees CJ, Mercurio C, Heierhorst J, McArthur GA. Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers. Cancer Res 2006; 66:8219-26.
23. Gastwirt RF, Slavin DA, Donoghue DJ. Spy1 expression prevents normal cellular responses to DNA damage: Inhibition of apoptosis and checkpoint activation. J Biol Chem 2006; 281:35425-35.
24. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001; 21:4129-39.
25. 2/M DNA damage checkpoint. Genes Dev 2000; 14:1448-59.
26. Guo Z, Kumagai A, Wang SX, Dunphy WG. Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev 2000; 14:2745-56.
27. Kumagai A, Kim SM, Dunphy WG. Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1. J Biol Chem 2004; 279:49599-608.
28. Shechter D, Costanzo V, Gautier J. ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol 2004; 6:648-55.
29. Shechter D, Gautier J. ATM and ATR check in on origins: A dynamic model for origin selection and activation. Cell Cycle 2005; 4.
30. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004; 5:792-804.
31. Shimuta K, Nakajo N, Uto K, Hayano Y, Okazaki K, Sagata N. Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition. Embo J 2002; 21:3694-703.
32. Golsteyn RM. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: A role beyond the cell cycle. Cancer Lett 2005; 217:129-38.
33. Kim SG, Kim SN, Jong HS, Kim NK, Hong SH, Kim SJ, Bang YJ. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Oncogene 2001; 20:1254-65.
34. Zhang Y, Fujita N, Tsuruo T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 1999; 18:1131-8.
35. Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, Roberts JM, Ross R. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade. Mol Cell 1998; 1:553-63.
36. Gervais JL, Seth P, Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J Biol Chem 1998; 273:19207-12.
37. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996; 10:1945-52.
38. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997; 14:929-35.